Clinical Trials
3 trialsNCT02143401 2024-11-22
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT04745403 2023-11-18
SAFE-T-HBV
Lion TCR Pte. Ltd.
Phase 1 Recruiting
NCT04032392 2019-07-25
Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells
Beijing 302 Hospital
Phase 1 Unknown